Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mercedes Robledo

Showing results (71-80 of 215) with videos related to

Pageof 22
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2016
Multilayer OMIC Data in Medullary Thyroid Carcinoma Identifies the STAT3 Pathway as a Potential Therapeutic Target in <i>RET</i><sup>M918T</sup> TumorsVeronika Mancikova, Cristina Montero-Conde, Javier Perales-Paton, et al.
Journal of Medical Genetics|June 19, 2013
Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathyLuis J Leandro-García, Lucía Inglada-Pérez, Guillermo Pita, et al.
Endocrine-Related Cancer|November 6, 2010
The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patientsSusanna Leskelä, Luis J Leandro-García, Marta Mendiola, et al.
Thyroid : Official Journal of the American Thyroid Association|November 1, 2016
APLP2, RRM2, and PRC1: New Putative Markers for the Differential Diagnosis of Thyroid Follicular LesionsEsmeralda Castelblanco, Carles Zafon, Javier Maravall, et al.
Clinical and Translational Medicine|December 30, 2020
Overexpression of miR-483-5p is confined to metastases and linked to high circulating levels in patients with metastatic pheochromocytoma/paragangliomaLuis Jaime Castro-Vega, Bruna Calsina, Nelly Burnichon, et al.
Endocrine-Related Cancer|January 16, 2010
Allelic variant at -79 (C>T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levelsIñigo Landa, Cristina Montero-Conde, Donatella Malanga, et al.
Human Pathology|January 3, 2012
Thyroid paraganglioma. Report of 3 cases and description of an immunohistochemical profile useful in the differential diagnosis with medullary thyroid carcinoma, based on complementary DNA array resultsEsmeralda Castelblanco, Pilar Gallel, Susana Ros, et al.
Human Mutation|February 22, 2007
Loss of the actin regulator HSPC300 results in clear cell renal cell carcinoma protection in Von Hippel-Lindau patientsAlberto Cascón, Beatriz Escobar, Cristina Montero-Conde, et al.
European Journal of Endocrinology|April 27, 2025
How ready are endocrine scientists to share retrospective clinical data for research: a perspective from the European Network for the Study of Adrenal TumorsAntoan Stefan Sojat, Bastien Rance, Antoine Neuraz, et al.
Neuroendocrinology|January 26, 2017
The mTORC1 Complex Is Significantly Overactivated in SDHX-Mutated ParagangliomasLindsey Oudijk, Thomas Papathomas, Ronald de Krijger, et al.
Pageof 22

Showing results (71-80 of 215) with videos related to

Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2016
Multilayer OMIC Data in Medullary Thyroid Carcinoma Identifies the STAT3 Pathway as a Potential Therapeutic Target in <i>RET</i><sup>M918T</sup> TumorsVeronika Mancikova, Cristina Montero-Conde, Javier Perales-Paton, et al.
Journal of Medical Genetics|June 19, 2013
Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathyLuis J Leandro-García, Lucía Inglada-Pérez, Guillermo Pita, et al.
Endocrine-Related Cancer|November 6, 2010
The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patientsSusanna Leskelä, Luis J Leandro-García, Marta Mendiola, et al.
Thyroid : Official Journal of the American Thyroid Association|November 1, 2016
APLP2, RRM2, and PRC1: New Putative Markers for the Differential Diagnosis of Thyroid Follicular LesionsEsmeralda Castelblanco, Carles Zafon, Javier Maravall, et al.
Clinical and Translational Medicine|December 30, 2020
Overexpression of miR-483-5p is confined to metastases and linked to high circulating levels in patients with metastatic pheochromocytoma/paragangliomaLuis Jaime Castro-Vega, Bruna Calsina, Nelly Burnichon, et al.
Endocrine-Related Cancer|January 16, 2010
Allelic variant at -79 (C>T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levelsIñigo Landa, Cristina Montero-Conde, Donatella Malanga, et al.
Human Pathology|January 3, 2012
Thyroid paraganglioma. Report of 3 cases and description of an immunohistochemical profile useful in the differential diagnosis with medullary thyroid carcinoma, based on complementary DNA array resultsEsmeralda Castelblanco, Pilar Gallel, Susana Ros, et al.
Human Mutation|February 22, 2007
Loss of the actin regulator HSPC300 results in clear cell renal cell carcinoma protection in Von Hippel-Lindau patientsAlberto Cascón, Beatriz Escobar, Cristina Montero-Conde, et al.
European Journal of Endocrinology|April 27, 2025
How ready are endocrine scientists to share retrospective clinical data for research: a perspective from the European Network for the Study of Adrenal TumorsAntoan Stefan Sojat, Bastien Rance, Antoine Neuraz, et al.
Neuroendocrinology|January 26, 2017
The mTORC1 Complex Is Significantly Overactivated in SDHX-Mutated ParagangliomasLindsey Oudijk, Thomas Papathomas, Ronald de Krijger, et al.
Pageof 22